FDA Inspection 1151264 — South Florida Institute For Reproductive Medicine

South Florida Institute For Reproductive Medicine — FEI 3007787718

The FDA completed an inspection of South Florida Institute For Reproductive Medicine on Sep 1, 2021 in Naples, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 1, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Naples, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.